| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3cd3ea6c52ef8544c67c051a2ef489b3 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-498
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate |
2015-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea0978460a0005b5098ed986d17c9425 |
| publicationDate |
2016-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2016132654-A |
| titleOfInvention |
Pharmacotherapy to prevent or treat glaucoma |
| abstract |
Disclosed is a pharmacotherapy for preventing or treating glaucoma or ocular hypertension, which has a strong intraocular pressure lowering action and an extended duration. 3,4-Dihydro-8- (2-hydroxy-3-isopropylamino) propoxy-3-nitroxy-2H-1-benzopyran or a salt thereof or a solvate thereof for the prevention or treatment of glaucoma And an α2 stimulant combination. [Selection figure] None |
| priorityDate |
2015-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |